Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
28 05 2020
Historique:
received: 27 03 2020
revised: 09 04 2020
accepted: 14 04 2020
pubmed: 4 5 2020
medline: 6 6 2020
entrez: 4 5 2020
Statut: ppublish

Résumé

Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2 infection and was first reported in central China in December 2019. Extensive molecular surveillance in Guangdong, China's most populous province, during early 2020 resulted in 1,388 reported RNA-positive cases from 1.6 million tests. In order to understand the molecular epidemiology and genetic diversity of SARS-CoV-2 in China, we generated 53 genomes from infected individuals in Guangdong using a combination of metagenomic sequencing and tiling amplicon approaches. Combined epidemiological and phylogenetic analyses indicate multiple independent introductions to Guangdong, although phylogenetic clustering is uncertain because of low virus genetic variation early in the pandemic. Our results illustrate how the timing, size, and duration of putative local transmission chains were constrained by national travel restrictions and by the province's large-scale intensive surveillance and intervention measures. Despite these successes, COVID-19 surveillance in Guangdong is still required, because the number of cases imported from other countries has increased.

Identifiants

pubmed: 32359424
pii: S0092-8674(20)30486-4
doi: 10.1016/j.cell.2020.04.023
pmc: PMC7192124
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

997-1003.e9

Subventions

Organisme : Medical Research Council
ID : MC_PC_19012
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S035362/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J014370/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S019510/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M010996/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M501621/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Auteurs

Jing Lu (J)

Guangdong Provincial Institution of Public Health, Guangzhou 511430, China; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Louis du Plessis (L)

Department of Zoology, University of Oxford, Oxford OX1 3SZ, UK.

Zhe Liu (Z)

Guangdong Provincial Institution of Public Health, Guangzhou 511430, China; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Verity Hill (V)

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH8 9YL, UK.

Min Kang (M)

Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Huifang Lin (H)

Guangdong Provincial Institution of Public Health, Guangzhou 511430, China; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Jiufeng Sun (J)

Guangdong Provincial Institution of Public Health, Guangzhou 511430, China; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Sarah François (S)

Department of Zoology, University of Oxford, Oxford OX1 3SZ, UK.

Moritz U G Kraemer (MUG)

Department of Zoology, University of Oxford, Oxford OX1 3SZ, UK.

Nuno R Faria (NR)

Department of Zoology, University of Oxford, Oxford OX1 3SZ, UK.

John T McCrone (JT)

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH8 9YL, UK.

Jinju Peng (J)

Guangdong Provincial Institution of Public Health, Guangzhou 511430, China; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Qianling Xiong (Q)

Guangdong Provincial Institution of Public Health, Guangzhou 511430, China; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Runyu Yuan (R)

Guangdong Provincial Institution of Public Health, Guangzhou 511430, China; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Lilian Zeng (L)

Guangdong Provincial Institution of Public Health, Guangzhou 511430, China; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Pingping Zhou (P)

Guangdong Provincial Institution of Public Health, Guangzhou 511430, China; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Chumin Liang (C)

Guangdong Provincial Institution of Public Health, Guangzhou 511430, China; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Lina Yi (L)

Guangdong Provincial Institution of Public Health, Guangzhou 511430, China; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Jun Liu (J)

Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Jianpeng Xiao (J)

Guangdong Provincial Institution of Public Health, Guangzhou 511430, China; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Jianxiong Hu (J)

Guangdong Provincial Institution of Public Health, Guangzhou 511430, China; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Tao Liu (T)

Guangdong Provincial Institution of Public Health, Guangzhou 511430, China; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Wenjun Ma (W)

Guangdong Provincial Institution of Public Health, Guangzhou 511430, China; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Wei Li (W)

Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Juan Su (J)

Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Huanying Zheng (H)

Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Bo Peng (B)

Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China.

Shisong Fang (S)

Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China.

Wenzhe Su (W)

Guangzhou Center for Disease Control and Prevention, Guangzhou 510440, China.

Kuibiao Li (K)

Guangzhou Center for Disease Control and Prevention, Guangzhou 510440, China.

Ruilin Sun (R)

Guangdong Provincial Second People's Hospital, Guangzhou 510320, China.

Ru Bai (R)

Guangdong Provincial Second People's Hospital, Guangzhou 510320, China.

Xi Tang (X)

Foshan First People's Hospital, Foshan 528000, China.

Minfeng Liang (M)

Foshan First People's Hospital, Foshan 528000, China.

Josh Quick (J)

Institute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK.

Tie Song (T)

Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.

Andrew Rambaut (A)

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH8 9YL, UK.

Nick Loman (N)

Institute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK.

Jayna Raghwani (J)

Department of Zoology, University of Oxford, Oxford OX1 3SZ, UK.

Oliver G Pybus (OG)

Department of Zoology, University of Oxford, Oxford OX1 3SZ, UK. Electronic address: oliver.pybus@zoo.ox.ac.uk.

Changwen Ke (C)

Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China. Electronic address: kecw1965@aliyun.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH